JAN 22, 2020 6:55 AM PST

Biosignatures detect TB infections months before symptoms appear

WRITTEN BY: Tara Fernandez

What if there was a test that could detect tuberculosis up to six months before symptoms appear? Researchers at the University of College London think a predictive diagnostic tool like this might soon become a reality, thanks to their work looking into gene expression patterns in the blood.

Tuberculosis, or TB, is caused by a slow-growing bacteria called Mycobacterium tuberculosis. This infectious pathogen thrives in oxygen-rich areas of the body, particularly the lungs, and is spread as coughs or sneezes propel it into the air. Immunocompromised people and those who live and work in crowded places such as healthcare facilities and prisons are especially at risk of contracting TB.

 

 

Diagnosis typically involves a tuberculin skin test to identify TB’s asymptomatic latent version. On the other hand, patients presenting with a persistent cough, fatigue, swelling of the lymph nodes or shortness of breath are likely to have the active form. This group is typically subjected to chest X-rays and sputum tests before physicians can make a positive TB diagnosis.

Globally, TB infections are among the top 10 causes of death, with the World Health Organization estimating that 10 million people contracted the disease in 2018. While it’s a condition that is preventable and treatable, a more accessible and reliable diagnostic remains to be developed.

Lead researcher Rishi Gupta hypothesized that mRNA biosignatures in patient blood samples could hold early, presymptomatic diagnostic clues, making them more valuable than traditional sputum samples. In research published in The Lancet Respiratory Medicine, Gupta and colleagues performed their analysis on genetic data collected from over 1000 blood samples, obtained from infected and healthy residents of South Africa, Ethiopia, The Gambia, and the UK. 

The team narrowed down potential mRNA candidates to a panel of 17 genes, which appeared to be consistently differentially expressed in TB-infected people over healthy controls. 

Speaking on the significance of their findings, Gupta said: "The emergence of gene expression signature tests, which can aid diagnosis and early treatment, provides real hope for the management of infectious diseases. In this study we identify multiple signatures to identify the onset of tuberculosis, which is extremely encouraging, potentially providing multiple targets for early detection.”

This is the first step towards a diagnostic blood test that could curtail the spread of TB, enable early antibiotic treatment interventions and prevent unnecessary deaths. 


Sources: Eurekalert, The Lancet Respiratory Medicine.

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
AUG 10, 2021
Drug Discovery & Development
Epidemiology and postexposure prophylaxis of rabies virus
AUG 10, 2021
Epidemiology and postexposure prophylaxis of rabies virus
Rabies is a viral disease that can be transmitted from an infected animal to another animal or human. In the U ...
AUG 29, 2021
Cancer
Blood Test over 90% Accurate in Detecting Lung Cancer
AUG 29, 2021
Blood Test over 90% Accurate in Detecting Lung Cancer
An AI-powered blood test was able to correctly detect the presence of lung cancer over 90% of the time in patient sample ...
SEP 16, 2021
Drug Discovery & Development
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
SEP 16, 2021
A shot for sore eyes: a novel injectable drug to treat age-related vision loss
According to the Population Reference Bureau, 40 million people in the United States are aged 65 and older. This nu ...
NOV 15, 2021
Cancer
Dogs Get Cancer Too
NOV 15, 2021
Dogs Get Cancer Too
“Cancer” isn’t a word anyone wants to hear from their doctor. However, many dog owners may not conside ...
NOV 12, 2021
Technology
Available Data for Cancer-Diagnosing AI Lacking Diverse Imagery
NOV 12, 2021
Available Data for Cancer-Diagnosing AI Lacking Diverse Imagery
The use of artificial intelligence to diagnose and monitor health conditions is on the rise. At its most basic level, AI ...
DEC 06, 2021
Clinical & Molecular DX
Bacterial Toxins and Advances in Detecting Bloodstream Infections
DEC 06, 2021
Bacterial Toxins and Advances in Detecting Bloodstream Infections
Sepsis describes the uncontrolled inflammatory response when the host cell is attacked by bloodstream infections. Sepsis ...
Loading Comments...